Epigenica launches fully managed platform for fast and reliable epigenomic insights
EpiFinder Analysis Service establishes a new standard for accessible, end-to-end epigenomic analysis, enabling researchers to move confidently from study concept to biological insights
6 Feb 2026
Epigenica AB has launched its EpiFinder™ Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic research faster, more accessible and highly reproducible.
The EpiFinder™ Analysis Service provides comprehensive, end-to-end support by managing every step of the workflow, from study design and sample logistics to sequencing, data processing, and final data delivery.
By minimizing hands-on requirements, through expert execution and standardized workflows, the service reduces technical variability and operational risks, shortening project timelines and enabling researchers to focus on biological interpretation rather than operational complexity.
With the capacity to process hundreds of samples weekly and the ability to analyze massive sequencing datasets, the platform supports both small- and large-scale studies. By managing the entire workflow within the Epigenica’s facility, consistent quality is ensured across the entire project.
EpiFinder™ Analysis Service provides high-resolution profiling of multiple histone modifications and DNA methylation in parallel through an integrated, automated pipeline that generates standardized outputs ready for analysis.
Complementing this, Epigenica’s scientific team offers comprehensive downstream support including identification of biological signatures, sample stratification, functional interpretation, customized data visualizations and guidance on multiomics data integration.
With turnaround times of 3 to 6 weeks and stringent quality control measures, the EpiFinder™ Analysis Service delivers high quality, reproducible results that accelerate epigenomic discovery.
Mohamad Takwa, CEO of Epigenica, said, “EpiFinder™ Analysis Service is designed to simplify and accelerate epigenomic research. We partner with our customers from the earliest stages, helping to shape the study, receiving and processing samples, analyzing the data, and delivering clear biological insights. By combining scale, speed, and scientific expertise, we offer a complete solution that researchers can trust.”